ArticleTransboundary and emerging diseases2025
Phylogenetic Characterization and Pathogenicity in Cattle and Pigs of Foot-and-Mouth Disease Viruses Circulating in Myanmar Between 2016 and 2022.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Evolution and Epidemiological Dynamics of Foot-and-Mouth Disease Virus O/ME-SA/Ind-2001e Circulating in East Java, Indonesia, in 2022-2025.Veterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease (FMD) is a highly contagious and serious transboundary disease affecting cloven-hoofed animals. Myanmar is a critical area for FMD outbreaks in Southeast and East Asian regions because of its geographical location bordering South Asian countries and its cattle industry. Phylogenetic characterization and pathogenicity in susceptible animals of circulating viruses in Myanmar are essential to prepare the rapid and accurate diagnosis and implement effective FMD prevention. This study analyzed a total of 34 vesicular epithelial samples collected from FMD cases in northern, central, and southern Myanmar between 2016 and 2022. Phylogenetic analysis of VP1 nucleotide sequences revealed multiple serotypes and topotypes between 2016 and 2019, including serotype O/Middle East-South Asia (ME-SA) topotype (O/ME-SA/Ind-2001e) and Southeast Asia (SEA) topotype, and serotype A/ASIA topotype. Subsequently, all viruses across Myanmar detected from 2019 to 2022 belonged to O/ME-SA/Ind-2001e. Phylogenetic analysis of the whole genome sequence showed that O/ME-SA/Ind-2001e viruses detected after 2019 were classified into a different genetic group with those of 2016 isolates in Myanmar. Based on phylogenetic analysis, one representative strain from 2019 that was genetically similar to viruses detected from 2019 to 2022 and to a 2022 Indonesian isolate was selected for pathogenicity testing in comparison with a 2016 strain closely related to viruses from neighboring countries. Both strains were used for experimental infection in pigs and showed similar pathogenicity. The 2019 strain was additionally tested in cattle and caused typical FMD pathogenicity, including vesicular development and virus excretion. Viral genes and antibodies in infected animals were detectable using existing diagnostic methods, which are considered useful for identifying currently circulating viruses. These results elucidate the subtypes of FMD viruses (FMDVs) circulating in Myanmar, their phylogenetic relationships with viruses from neighboring Asian countries, their pathogenicity, and the applicability of available diagnostic methods. It offers insights into appropriate control strategies against FMD in Southeast and East Asian regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.